Skip to main content
International Journal of Epidemiology logoLink to International Journal of Epidemiology
. 2014 Mar 16;43(4):1240–1251. doi: 10.1093/ije/dyu042

Distribution of mammographic density and its influential factors among Chinese women

Hongji Dai 1,†,, Ye Yan 1,†,, Peishan Wang 1, Peifang Liu 2, Yali Cao 3, Li Xiong 3, Yahong Luo 4, Tie Pan 5, Xiangjun Ma 6, Jie Wang 6, Zhenhua Yang 1, Xueou Liu 1, Chuan Chen 1, Yubei Huang 1, Yi Li 7, Yaogang Wang 8, Xishan Hao 1,9, Zhaoxiang Ye 7,*, Kexin Chen 1,*
PMCID: PMC4121553  PMID: 24639441

Abstract

Background: Mammographic density (MD) has not been systematically investigated among Chinese women. Breast cancer screening programmes provided detailed information on MD in a large number of asymptomatic women.

Methods: In the Multi-modality Independent Screening Trial (MIST), we estimated the association between MD and its influential factors using logistic regression, adjusting for age, body mass index (BMI) and study area. Differences between Chinese and other ethnic groups with respect to MD were also explored with adjustment for age and BMI.

Results: A total of 28 388 women aged 45 to 65 years, who had been screened by mammography, were enrolled in the study. Of these, 49.2% were categorized as having dense breasts (BI-RADS density 3 and 4) and 50.8% as fatty breasts (BI-RADS density 1 and 2). Postmenopausal status [odds ratio (OR) = 0.66; 95% confidence interval (CI): 0.62–0.70] and higher number of live births (OR = 0.56; 95% CI: 0.46–0.68) were inversely associated with MD, whereas prior benign breast disease (OR = 1.48; 95% CI: 1.40–1.56) and later age at first birth (OR = 1.17; 95% CI: 1.08–1.27) were positively associated with MD. In comparison with the data from the Breast Cancer Surveillance Consortium, we found that women in MIST were more likely to have fatty breasts than Americans (from the Breast Cancer Surveillance Consortium) in the older age group (≥50 years) but more likely to have dense breasts in the younger age group (<50 years).

Conclusions: This study suggests that several risk factors for breast cancer were associated with breast density in Chinese women. Information on the determinants of mammographic density may provide valuable insights into breast cancer aetiology.

Keywords: Mammography, breast density, hormone, reproduction, ethnicity


Key Messages.

  • In the current literature, there were no data regarding breast density available for a representative sample of asymptomatic Chinese women.

  • In this present study, we found that postmenopausal status and more parity were inversely associated with MD whereas prior breast benign disease and later age at first birth were positively associated with MD in Chinese women.

  • We found the breasts of Chinese women were fattier than those of American women in the older age group, but the opposite was found in the younger age group.

Introduction

Breast cancer is one of the most frequently diagnosed cancers among Chinese women. The incidence of female breast cancer was 47.64 per 100 000 in 2008, and the rate was 1.6 times higher in urban areas than in rural areas.1 Several genetic and environmental factors have been reported to be associated with an increased risk of breast cancer, including mutations in BRCA1 and BRCA2, family or personal history of breast cancer, advanced age, nulliparity, short lifetime duration of breastfeeding, early menarche and older age at menopause.2,3

Breast density, a reflection of breast tissue composition, is reported to be associated with breast cancer risk, sometimes more strongly than most of the other risk factors for this disease.4 Higher breast density has repeatedly been shown to be associated with increased risk of breast cancer among White, African American and Asian American women,5–8 but there is currently no information available for Mainland Chinese women. Breast density was usually assessed by mammography and classified by Wolfe,9 Tabar10 and the Breast Imaging Reporting and Data System (BI-RADS)11 qualitatively. The BI-RADS classification system, developed by the American College of Radiology, ranks the amount of mammographically dense (white in image) relative to the total projected breast area into four consecutive categories. In recent years, the BI-RADS category has been widely used in clinical practice for diagnostic mammography and mammographic density (MD) measurement in China.

The percentage of dense breasts (BI-RADS density 3 and 4) in White women ranged from 35% to 61% at different ages,7 amd Asian women were reported to have a higher proportion of dense breasts than other ethnicities.7,12,13 Since large-scale mammography screening has not previously been carried out in China , there were no data on breast density available for a representative sample of asymptomatic Chinese women. There was a need to evaluate differences in breast density between Chinese and other ethnicities.

Mammographic density varies among individuals. Age and body mass index (BMI) are strong influential factors for mammographic density.14–16 Several known breast cancer risk factors, including hormonal and reproductive factors, were reported to be associated with mammographic breast density.17–20 Analysis from genome-wide association studies (GWAS) suggested that mammographic density and breast cancer have a shared genetic basis.21,22 However, the magnitude of the influence of breast cancer risk factors on mammographic density in Chinese women is largely unknown.

The current study presents the distribution of mammographic density and examines the associations between known and suspected breast cancer risk factors and breast density among a large number of women attending the Multi-modality Independent Screening Trial (MIST) in China. To examine the possible ethnic differences in mammographic density, variations in densities between Chinese women and other ethnicities were also evaluated.

Methods

Study population

This study was approved by Tianjin Medical University Cancer Institute and Hospital (TMUCIH) Institutional Review Board. All participants provided written informed consent before breast cancer screening was performed. Study subjects were identified from a Multi-modality Independent Screening Trial (MIST), resident in one of the four geographical areas (Tianjin, Nanchang, Beijing and Shenyang) in China. The MIST study was initiated by the Chinese Anti-Cancer Association (CACA) and conducted between 1 July 2008 and 30 December 2010. In this trial, asymptomatic women aged 45–65 years, who had lived in their residential communities for ≥3 years, and had not previously been diagnosed with breast cancer, were invited to the screening according to a cluster sampling. The participation rate was 85.13%. Eligible women were examined by clinical breast examination (CBE), mammography (MAM) and breast ultrasound (BUS). A blinding method was used to keep each screening test independent by not informing the examiners of each preceding result prior to their performing successive tests. All patients who were determined by their primary physicians to have a lesion considered suspicious or highly suggestive of a malignancy with any modality, were scheduled for a biopsy. Participants in MIST were followed up annually to validate the true negative results.

Women with data on both digitized images and mammographic density measurements were included in this study. Among the 34 964 eligible women in the MIST trial, 6357 (18.2%) lacked mammographic density information and 219 (0.6%) were outside the age range of 45–65 years. As a result, mammographic density with a BI-RADS density category was recorded for 28 388 (81.2%) of the screening subjects.

Questionnaire data and variable definitions

A face-to-face interview questionnaire collected information regarding demographical data, hormonal and reproductive factors, breast disease history, family history of breast cancer, behaviour patterns and social/psychological characteristics. Age at screening, body weight (kg) and height (m) were acquired by personal report. Body mass index (BMI) was calculated as the weight divided by the height squared (kg/m2).

Items related to hormonal and reproductive factors included age at menarche, menopausal status, number of live births, age at first birth, hormone use and ever suffered from dysmenorrhoea. Women who reported no menstruation during the past 12 months were considered postmenopausal. Ages at first birth were grouped using a cutoff of 30 and nulliparous women were excluded from the analysis. Dysmenorrhoea refers to women who had ever suffered from pain during menstruation that had disturbed their daily activities. Hormone use included estrogens alone and estrogens in combination with a progestin for treatment of menopausal syndrome. Breast disease history only included benign breast disease such as hyperplasia and fibroadenoma. Family history of breast cancer was defined as breast cancer occurring in first-degree relatives (mother, sisters or daughters). Ever smoking was defined as at least one cigarette per day for ≥3 months. Ever having drunk alcohol was defined as at least 50 ml liquor per week.

Variation in the distribution of mammographic density by ethnicity was compared between Chinese women from the MIST study and American women from the Breast Cancer Surveillance Consortium (BCSC)23 in the same age and BMI groups. A dataset with 280 660 records was obtained from BCSC Research Resource (http://breastscreening.cancer.gov/). We included women (non-Hispanic White, African American and Asian/Pacific Islanders) aged 45 to 64 years with no missing data on breast density category and BMI. We also extracted another four variables (i.e. menopausal status, age at first birth, family history of breast cancer, and hormone use) for adjustment. As a result, a total of 36 719 records were selected from the database for this comparison.

Mammography performance and assessment of breast density

During mammography screening, craniocaudal (CC) and mediolateral oblique (MLO) views were used to calculate density measures. Bilateral mammograms were obtained using a full-field digital mammography system (Senographe 2000D, General Electric, and Selenia Digital Mammography, Hologic). Qualitative assessment was according to the BI-RADS coding system,11 with category 1 indicating breast tissue that was less than 25% glandular or almost entirely fat; category 2, breast tissue that was approximately 25–50% glandular or scattered fibroglandular; category 3, breast tissue that was 51–75% glandular or heterogeneously dense; and category 4, breast tissue that was more than 75% glandular or extremely dense. The density assessments were performed by radiologists who had been trained by Z.Y. before the study began at each screening site. The readers were blinded to all subject characteristics.

Statistical analysis

In order to increase the degree of certainty about the density measurement, MD was analysed as a dichotomous outcome, by comparing women with dense breasts (BI-RADS category 3 and 4) with those with fatty breasts (BI-RADS category 1 and 2). Kappa coefficient (κ) was calculated to generate the agreement index between readers.

The association between breast density and breast cancer risk, and the association between breast density and potential breast cancer risk factors, were measured by unconditional logistic regression, controlling for other factors including age at screening (continuous), BMI (continuous), and study area (categorical). Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated for the association between mammographic patterns and the selected factors. In addition, we reported the associations between MD and risk factors in different study areas and performed a meta-analysis to combine the results from these regions. Random effect model was used when there was heterogeneity among the four regional groups and fixed effect model when there was no heterogeneity among these groups. The I2 statistic was calculated to determine the degree of heterogeneity.

Variation in the distribution of mammographic density by ethnicity was compared among Chinese, White, Asian American and African American women, stratified by age and adjusted for BMI. Stratified analyses were done within each age group (45–49, 50–54, 55–59 and 60–64 years) and BMI group (<25 and ≥25 kg/m2). Unconditional logistic regression was performed for dense breasts (BI-RADS density 3 and 4) relative to fatty breasts (BI-RADS density 1 and 2) and adjusted OR with 95% CI was calculated.

All statistical tests were two-sided. Analyses were performed using the SPSS 16.0 package. Meta-analysis was conducted with software Review Manager (version 5.1).

Quality control

For quality control, all assessments of breast density were double-checked at primary screening sites. A subsample of films (N = 6167) was sent to TMUCIH and re-read by two radiologists (Y.L. and Z.Y.) throughout the entire study. A concordance analysis was undertaken to assess intra-observer and inter-observer agreement between the first and the second readings. Average intra-observer agreement was substantial (κ = 0.74 on a four-grade scale) and even higher [κ = 0.92 on a two-grade scale (1–2 and 3–4)]. Average inter-observer agreement was moderate (κ = 0.49 on a four-grade scale) and substantial (κ = 0.64 on a two-grade scale).

Results

Baseline characteristics of the study participants

In each study area, the distributions of age and BMI were comparable between participants who were included in this analysis and those who were not (data not shown). Demographic characteristics of the study participants in the four geographical areas are shown in Table 1. For the whole study population, the mean age at screening was 51.81 (±5.20) years, and 44.4% of the participants were premenopausal. Among the women included, 66.2% had more than 9 years of education; smokers (2.5%) and alcohol drinkers (4.0%) were rare. The mean BMI was 23.60 (±3.03) kg/m2. Nearly 3% of the women reported a family history of breast cancer, and 34.3% reported having ever had one or more benign breast diseases. About 2% of the participants reported ever having used hormones. Significant differences (P < 0.001) were found among the four areas for each variable mentioned above due to the large number of participants included in the analysis.

Table 1.

Baseline characteristics of the study participants in four areas in China

Characteristic Area
Nanchang Tianjin Shenyang Beijing Total
(N = 9008) (N = 7052) (N = 6433) (N = 5895) (N = 28388)
Age (years)
    Mean ± SD 51.4 ± 5.2 53.4 ± 5.3 52.1 ± 5.1 50.2 ± 4.7 51.8 ± 5.2
BMI (kg/m2)
    Mean ± SD 22.7 ± 2.9 24.3 ± 3.2 23.6 ± 2.9 24.1 ± 2.9 23.6 ± 3.0
Marriage age (years)
    Mean ± SD 24.3 ± 3.1 26.6 ± 3.7 25.7 ± 3.5 25.3 ± 4.4 25.4 ± 3.7
Marital status
    Married 8618 (95.7) 6696 (95.0) 5997 (93.2) 5599 (95.0) 26910 (94.8)
    Sgl/div/sep/wida 377 (4.2) 319 (4.5) 436 (6.8) 242 (4.1) 1374 (4.8)
    Unknown 13 (0.1) 37 (0.5) 0 (0.0) 54 (0.9) 104 (0.4)
Menopausal status
    Pre 4580 (50.8) 2054 (29.1) 2564 (39.9) 3403 (57.7) 12601 (44.4)
    Post 4398 (48.8) 4822 (68.4) 3868 (60.1) 2385 (40.5) 15473 (54.5)
    Unknown 30 (0.3) 176 (2.5) 1 (0.0) 107 (1.8) 314 (1.1)
Education duration
    ≤9 years 3339 (37.1) 2721 (38.6) 2163 (33.6) 1230 (20.9) 9453 (33.3)
    >9 years 5632 (62.5) 4300 (61.0) 4270 (66.4) 4605 (78.1) 18807 (66.2)
    Unknown 37 (0.4) 31 (0.4) 0 (0.0) 60 (1.0) 128 (0.5)
Family income (per month, RMB)
    <1000 735 (8.2) 527 (7.5) 751 (11.7) 119 (2.0) 2132 (7.5)
    1000-1999 2284 (25.4) 1641 (23.3) 1548 (24.1) 387 (6.6) 5860 (20.6)
    2000-2999 2595 (28.8) 2173 (30.8) 1482 (23.0) 1194 (20.3) 7444 (26.2)
    3000-4999 2304 (25.6) 1656 (23.5) 1584 (24.6) 2256 (38.3) 7800 (27.5)
    ≥5000 1065 (11.8) 799 (11.3) 1068 (16.6) 1680 (28.5) 4612 (16.2)
    Unknown 25 (0.3) 256 (3.6) 0 (0.0) 259 (4.4) 540 (1.9)
Medical expenditure
    Self-paying 2577 (28.6) 484 (6.9) 473 (7.4) 435 (7.4) 3969 (14.0)
    Medical insurance 4764 (52.9) 6015 (85.3) 5491 (85.4) 3719 (63.1) 19989 (70.4)
    Rural cooperative medical care 88 (1.0) 13 (0.2) 23 (0.4) 305 (5.2) 429 (1.5)
    Free medical service 1557 (17.3) 368 (5.2) 446 (6.9) 1279 (21.7) 3650 (12.9)
    Unknown 22 (0.2) 172 (2.4) 0 (0.0) 157 (2.7) 351 (1.2)

SD, standard deviation.

aSingle, divorced, separated or widowed.

Mammographic density distribution and breast cancer risk

Overall, women in this study had a large percentage of ‘scattered fibroglandular’ (38.4%) and ‘heterogeneously dense’ breasts (40.6%), compared with a minority of ‘almost entirely fat’ (12.4%) and ‘extremely dense’ breasts (8.6%). The proportion of mammographically dense breasts decreased with age (Ptrend < 0.001) and BMI (Ptrend < 0.001) (Supplementary Table 1, available as Supplementary data at IJE online).

Distribution of mammographic density was compared between the screening-detected cancer cases (N = 86) and the healthy women (N = 28 302) in the screening. Compared with women in category 1, women in category 2 (OR = 2.06; 95% CI: 0.95–4.48), category 3 (OR = 2.06; 95% CI: 0.90–4.68) and category 4 (OR = 1.45; 95% CI: 0.41–5.15) had increased, but not statistically significant, risk of breast cancer (Table 2). When compared within specific age and BMI groups, this result did not change substantially (data not shown).

Table 2.

Distribution of mammographic density of screen-detected cancer cases and the healthy women

BI-RADs density category Breast cancer N (%) No breast cancer N (%) OR (95% CI)a
Category 1 8 (9.3) 3518 (12.4) 1.00
Category 2 40 (46.5) 10868 (38.4) 2.06 (0.95, 4.48)
Category 3 34 (39.5) 11483 (40.6) 2.06 (0.90, 4.68)
Category 4 4 (4.7) 2433 (8.6) 1.45 (0.41, 5.15)
P trend 0.353

aOdds ratio adjusted by age, BMI and study area for breast cancer relative to no breast cancer.

Factors associated with mammographic density

Reproductive and hormonal factors and potential risk factors for breast cancer were compared between women with dense breasts and those with fatty breasts. Generally, postmenopausal status (OR = 0.66; 95% CI: 0.62–0.70) and more live births (OR = 0.56; 95% CI: 0.46–0.68 for number ≥2 and OR = 0.82; 95% CI: 0.68–0.98 for number = 1, compared with number = 0) were negatively associated with MD. Prior benign breast disease (OR = 1.48; 95% CI: 1.40–1.56) and later age at first birth (OR = 1.17; 95% CI: 1.08–1.27 for age ≥30 compared with age <30 years) were positively associated with MD (Table 3).

Table 3.

Association of mammographic density and potential breast cancer risk factors

Variables Density category, N (%)
OR (95% CI)a
➀ <25% ➁ 25-50% ➂ 51-75% ➃ >75%
Age at menarche, years
    ≤12 323 (9.7) 1139 (34.1) 1536 (45.9) 346 (10.3) 1.00
    >12 3193 (12.8) 9739 (39.0) 9939 (39.8) 2088 (8.4) 0.97 (0.89, 1.05)
Menopause
    Pre 733 (5.8) 3873 (30.7) 6333 (50.3) 1662 (13.2) 1.00
    Post 2775 (17.9) 6952 (44.9) 5019 (32.4) 727 (4.7) 0.66 (0.62, 0.70)*
Number of live births
    0 31 (5.6) 199 (36.1) 256 (46.5) 65 (11.8) 1.00
    1 2097 (9.3) 8437 (37.5) 9785 (43.5) 2181 (9.7) 0.82 (0.68, 0.98)**
    ≥2 1254 (26.7) 2068 (44.1) 1222 (26.1) 145 (3.1) 0.56 (0.46, 0.68)*
Age at first birth, years
    <30 3099 (12.6) 9391 (38.3) 9902 (40.4) 2111 (8.6) 1.00
    ≥30 351 (11.6) 1211 (40.0) 1230 (40.7) 232 (7.7) 1.17 (1.08, 1.27)*
Hormone use
    Never 3291 (12.6) 10059 (38.6) 10506 (40.3) 2235 (8.6) 1.00
    Ever 235 (10.2) 849 (37.0) 1010 (44.0) 202 (8.8) 1.01 (0.92, 1.12)
Dysmenorrhoea
    Never 2532 (12.7) 7568 (38.1) 8035 (40.5) 1728 (8.7) 1.00
    Ever 967 (11.7) 3248 (39.3) 3355 (40.6) 689 (8.3) 1.01 (0.96, 1.07)
Family history of breast cancer
    No 3447 (12.5) 10584 (38.4) 11189 (40.6) 2362 (8.6) 1.00
    Yes 79 (9.8) 324 (40.2) 328 (40.7) 75 (9.3) 1.09 (0.93, 1.27)
Prior breast benign disease
    No 2693 (14.8) 7432 (40.7) 6919 (37.9) 1199 (6.6) 1.00
    Yes 799 (8.2) 3306 (33.9) 4429 (45.4) 1212 (12.4) 1.48 (1.40, 1.56)*
Ever smoking
    No 3397 (12.5) 10502 (38.5) 11026 (40.4) 2335 (8.6) 1.00
    Yes 94 (13.4) 244 (34.8) 296 (42.2) 67 (9.6) 1.11 (0.94, 1.31)
Ever alcohol drinking
    No 3369 (12.6) 10244 (38.4) 10780 (40.4) 2272 (8.5) 1.00
    Yes 102 (9.0) 423 (37.5) 485 (43.0) 118 (10.5) 1.06 (0.93, 1.21)

aOdds ratio adjusted by age, BMI and study area for dense breasts (BI-RADS 3 + 4) relative to fatty breasts (BI-RADS 1 + 2).

*P < 0.001.

**P = 0.033.

Forest plots from meta-analysis for the association between mammographic density and its influential factors by study areas showed that later age at menarche (OR = 0.85; 95% CI: 0.79–0.92), postmenopausal status (OR = 0.43; 95% CI: 0.30–0.62) and more live births (OR = 0.30; 95% CI: 0.19–0.46) were negatively associated with MD, whereas prior benign breast disease (OR = 1.57; 95% CI: 1.38–1.78) was positively associated with MD (Figure 1). There is significant heterogeneity for menopausal status, number of live births, age at first birth and prior breast benign disease among the four study areas.

Figure 1.

Figure 1.

Figure 1.

Figure 1.

Forest plot of overall analysis for the association between mammographic density and its influential factors by study areas. (M-H: Mantel-Haenszel)

Variation in the distribution of mammographic density by ethnicity

Data of women aged 45–64 years in the BCSC were used for this comparison. Baseline characteristics of Chinese women and American women are shown in Supplementary Table 2, available as Supplementary data at IJE online. Mammographic density distribution of Chinese women within the ages of 45 to 64 years was compared with that of women in USA, and significant differences were found in Whites (P < 0.001), Asian Americans (P < 0.001) and African Americans (P < 0.001). Overall, dense breasts (BI-RADS density 3 and 4) accounted for 49.49% in Chinese, 48.77% in Whites, 61.66% in Asian Americans and 46.15% in African Americans. When stratified by age, Chinese women have denser breasts than American women only in those aged <50 years. In other age groups, the results were the opposite (Table 4). When further compared with different races, breasts of Chinese women were denser than those of Whites in age <50 group but fattier than those of other women in age ≥50 group. Chinese women have fattier breasts compared with Asian Americans and African Americans except in young women in high BMI groups (Supplementary Tables 3–5, available as Supplementary data at IJE online).

Table 4.

Mammographic density distribution between Chinese and American women

Race Age < 50, N (%)
Age ≥ 50, N (%)
Fatty Dense OR (95% CI)a Fatty Dense OR (95% CI)a
Chinese 595 (5.2) 10754 (94.8) 1.00 2816 (16.9) 13863 (83.1) 1.00
White 936 (13.1) 6225 (86.9) 0.60 (0.53, 0.69)* 3561 (16.5) 18084 (83.5) 1.52 (1.43, 1.62)*
Asian American 41 (4.1) 961 (95.9) 1.85 (1.30, 2.62)* 209 (6.4) 3038 (93.6) 3.67 (3.15, 4.27)*
African American 98 (10.2) 862 (89.8) 1.18 (0.86, 1.61) 389 (14.4) 2315 (85.6) 2.25 (1.94, 2.61)*

aOdds ratio adjusted by BMI for dense breasts (BI-RADS 2 to 4) vs (BI-RADS 1).

*P < 0.001.

Since large differences in MD between Chinese women and Asian American women were found, we compared Chinese women participating in MIST in the four study areas separately. All women living in Nanchang, Tianjin and Shenyang and older women in Beijing had fattier breasts compared with Asian Americans (Supplementary Tables 6–8, available as Supplementary data at IJE online). Denser breasts (BI-RADS density 3 and 4) were only found in women in Beijing with ages between 45 and 49 years and BMIs ≥25 kg/m2 (Supplementary Table 9, available as Supplementary data at IJE online).

Discussion

In the present study, we examined the distribution of the mammographic density in Chinese populations and assessed its associations with several potential breast cancer risk factors. In the analysis, we found differences in mammographic density distribution between women in China and women in the USA. This is the first time we have been able to systematically determine the potential role of mammographic density, a recognized risk factor among Western women, in breast cancer risk among women living in Mainland China.

Although it has been reported that mammographic density is a strong risk factor for breast cancer,4 we did not find this association among women participating in the MIST. This may be due to the small numbers of cancer cases detected through screening, and needs further study with larger sample sizes to validate. The association of mammographic density with most hormone-related factors was consistent with that in previous reports,24–26 supporting the hypothesis that mammographic density represents accumulated exposure to risk factors that may stimulate growth of breast cells and cause breast cancer. Hormone use has been thought to increase breast density, though no associations were found in this study when adjusting for age, BMI and study area. This may be due to the scarcity of hormone users among the participating women. Older age, BMI, parity and menopause are reported to be associated with reductions in the epithelial and stoma tissues in the breasts, with an increase in fat. These histological changes are reflected in the mammographic images, suggesting that the mammographic density can be used for monitoring breast cancer risk.

Smoking and alcohol drinking habits are inconsistently associated with mammographic density. Tobacco smoke could exert an anti-estrogenic effect on breast tissue and could have a negative relation to mammographic density,27–30 although no association was reported in other studies.31,32 Alcohol consumption may have an influence on breast neoplasm formation. It remains unclear whether alcohol consumption increases the mammographic density, with both positive associations33–35 and null association36 reported previously. Our study did not find an association between alcohol consumption and smoking habits and mammographic density.

We did not find an increased mammographic density in familial subjects of the overall participants, as has been reported in some other studies. For example, it was reported that women with higher breast density were more likely to have a first-degree relative who had breast cancer than women with lower breast density,37,38 suggesting an association that may be the result of shared genetic and/or environmental factors among family members, which may affect breast density and breast cancer risk. Our negative result may be due to the low percentage of family history of breast cancer among Chinese women, possibly due to population difference.

Therefore, we compared population difference related to mammographic density between Chinese and Whites, African Americans and Asian/Pacific islanders of inhabitants in the USA. Comparison with previously published data may be biased, due to different MD category26,39 or unmatched age and BMI.7,40–43 Because a large number of our study participants were less than 50 years old, and in order to avoid losing information, we used data of US women from the BCSC website to acquire a comparative narrow age range. By comparison, we found that the density categories of Chinese women were fattier than those of American women in the older age group, which is not consistent with what has been reported in the literature, in which the proportion of women with extremely dense breasts was the greatest among Asian women in all age ranges.7 In recent decades, greatly influenced by the government ‘one-child’ policy, reproduction behaviour in China has changed significantly.44 As a result, the decreased number of childbirths, which are known to be associated with high mammographic density,45 have predominantly impacted on younger Chinese women. This may explain the age discrepancy on mammographic density we have observed. The discrepancy of mammographic density between Mainland Chinese women and Chinese women living abroad is probably due to the different origins of population, which still need future investigations.

Limitations of this study could result from visual estimation of mammographic density. Though characterization of breast density by mammography has several limitations,4 none of the other established means of measuring mammographic density is entirely satisfactory, because all are time consuming or subjective.45 Visual scales of mammographic density using BI-RADS were reported to be highly reproducible and concordant when appropriate training is provided.46 Our data were collected from well-established hospitals in four cities in China, utilizing the skills of senior radiologists, although not representing all parts of China. There may exist a large difference in diagnosis between radiologists in China and the USA, which also needs further validation.

Supplementary Data

Supplementary data are available at IJE online

Funding

This work was supported partially by the National Natural Science Foundation of China [Grant 81172762], programme for Changjiang Scholars and Innovative Research Team in University in China [Grant IRT1076], National Key Scientific and Technological Project [Grants 2011ZX09307–701–14 and 2014BAI09B09], Tianjin Science and Technology Committee Foundation [Grants 09ZCZDSF04700, 09ZCZDSF04800, 11ZCGYSY02200, 12ZCDZSY15500 and 12ZCDZSY16000] and the Special fund on National Public Health [200902002–2].

Data collection for BCSC’s work was supported by a NCI-funded Breast Cancer Surveillance Consortium [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731 and U01CA70040].

Supplementary Material

Supplementary Data

Acknowledgements

We thank the local doctors and the women who participated in our study from Tianjin, Liaoning, Beijing and Jiangxi provinces, as well as the Ministry of Health P.R China and the Chinese Anti-Cancer Association for their generous support. We also thank Professors Wei Zhang and Qingyi Wei from University of Texas MD Anderson Cancer Center for editing this manuscript.

Conflict of interest: None declared.

References

  • 1.National Cancer Center. Disease Prevention and Control Bureau, Ministry of Health. Chinese Cancer Annual Report 2011 . Beijing: Military Medical Science Press, 2012. [Google Scholar]
  • 2.Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002;360:187–95. [DOI] [PubMed] [Google Scholar]
  • 3.Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 2012;13:1141–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S. Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst 2010;102:1224–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227–36. [DOI] [PubMed] [Google Scholar]
  • 6.McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159–69. [DOI] [PubMed] [Google Scholar]
  • 7.Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 2008;148:337–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ursin G, Ma H, Wu AH, et al. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 2003;12:332–38. [PubMed] [Google Scholar]
  • 9.Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 1976;37:2486–92. [DOI] [PubMed] [Google Scholar]
  • 10.Tabar L, Tot T, Dean PB. Introduction. The normal breast: comparative subgross anatomy and mammography. In: Tabar L, Tot T, Dean PB. (eds). Breast Cancer. The Art and Science of Early Detection With Mammography . 1st edn New York: Thieme, 2005. [Google Scholar]
  • 11.American College of Radiology. Breast imaging reporting and data system (BI-RADS). 4th edn Reston, VA: American College of Radiology, 2003. [Google Scholar]
  • 12.del Carmen MG, Halpern EF, Kopans DB, et al. Mammographic breast density and race. AJR Am J Roentgenol 2007;188:1147–50. [DOI] [PubMed] [Google Scholar]
  • 13.Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 2004;13:2090–95. [PubMed] [Google Scholar]
  • 14.Dite GS, Stone J, Chiarelli AM, et al. Are genetic and environmental components of variance in mammographic density measures that predict breast cancer risk independent of within-twin pair differences in body mass index? Breast Cancer Res Treat 2012;131:553–59. [DOI] [PubMed] [Google Scholar]
  • 15.Harris HR, Tamimi RM, Willett WC, Hankinson SE, Michels KB. Body size across the life course, mammographic density, and risk of breast cancer. Am J Epidemiol 2011;174:909–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Titus-Ernstoff L, Tosteson AN, Kasales C, et al. Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control 2006;17:1281–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Dite GS, Gurrin LC, Byrnes GB, et al. Predictors of mammographic density: insights gained from a novel regression analysis of a twin study. Cancer Epidemiol Biomarkers Prev 2008;1:3474–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Riza E, Remoundos DD, Bakali E, Karadedou-Zafiriadou E, Linos D, Linos A. Anthropometric characteristics and mammographic parenchymal patterns in post-menopausal women: a population-based study in Northern Greece. Cancer Causes Control 2009;20:181–91. [DOI] [PubMed] [Google Scholar]
  • 19.Ursin G, Lillie EO, Lee E, et al. The relative importance of genetics and environment on mammographic density. Cancer Epidemiol Biomarkers Prev 2009;18:102–12. [DOI] [PubMed] [Google Scholar]
  • 20.Vachon CM, Sellers TA, Carlson EE, et al. Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res 2007;67:8412–18. [DOI] [PubMed] [Google Scholar]
  • 21.Lindstrom S, Vachon CM, Li J, et al. Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet 2011;43:185–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Varghese JS, Thompson DJ, Michailidou K, et al. Mammographic breast density and breast cancer: evidence of a shared genetic basis. Cancer Res 2012;72:1478–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Barlow WE, White E, Ballard-Barbash R, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 2006;98:1204–14. [DOI] [PubMed] [Google Scholar]
  • 24.El-Bastawissi AY, White E, Mandelson MT, Taplin SH. Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control 2000;11:955–63. [DOI] [PubMed] [Google Scholar]
  • 25.Tehranifar P, Reynolds D, Flom J, et al. Reproductive and menstrual factors and mammographic density in African American, Caribbean, and white women. Cancer Causes Control 2011;22:599–610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wong CS, Lim GH, Gao F, et al. Mammographic density and its interaction with other breast cancer risk factors in an Asian population. Br J Cancer 2011;104:871–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bremnes Y, Ursin G, Bjurstam N, Gram IT. Different measures of smoking exposure and mammographic density in postmenopausal Norwegian women: a cross-sectional study. Breast Cancer Res 2007;9:R73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Butler LM, Gold EB, Conroy SM, et al. Active, but not passive cigarette smoking was inversely associated with mammographic density. Cancer Causes Control 2010;21:301–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Jeffreys M, Warren R, Gunnell D, McCarron P, Davey Smith G. Life course breast cancer risk factors and adult breast density (United Kingdom). Cancer Causes Control 2004;15:947–55. [DOI] [PubMed] [Google Scholar]
  • 30.Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 2000;11:653–62. [DOI] [PubMed] [Google Scholar]
  • 31.Gapstur SM, Lopez P, Colangelo LA, Wolfman J, Van Horn L, Hendrick RE. Associations of breast cancer risk factors with breast density in Hispanic women. Cancer Epidemiol Biomarkers Prev 2003;12:1074–80. [PubMed] [Google Scholar]
  • 32.Roubidoux MA, Kaur JS, Griffith KA, Stillwater B, Novotny P, Sloan J. Relationship of mammographic parenchymal patterns to breast cancer risk factors and smoking in Alaska Native women. Cancer Epidemiol Biomarkers Prev 2003;12:1081–86. [PubMed] [Google Scholar]
  • 33.Cabanes A, Pastor-Barriuso R, Garcia-Lopez M, et al. Alcohol, tobacco, and mammographic density: a population-based study. Breast Cancer Res Treat 2011;129:135–47. [DOI] [PubMed] [Google Scholar]
  • 34.Voevodina O, Billich C, Arand B, Nagel G. Association of Mediterranean diet, dietary supplements and alcohol consumption with breast density among women in South Germany: a cross-sectional study. BMC Public Health 2013;13:203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Yaghjyan L, Mahoney MC, Succop P, Wones R, Buckholz J, Pinney SM. Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort. Br J Cancer 2012;106:996–1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Qureshi SA, Couto E, Hofvind S, Wu AH, Ursin G. Alcohol intake and mammographic density in postmenopausal Norwegian women. Breast Cancer Res Treat 2012;131:993–1002. [DOI] [PubMed] [Google Scholar]
  • 37.Crest AB, Aiello EJ, Anderson ML, Buist DS. Varying levels of family history of breast cancer in relation to mammographic breast density (United States). Cancer Causes Control 2006;17:843–50. [DOI] [PubMed] [Google Scholar]
  • 38.Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K. Mammographic breast density and family history of breast cancer. J Natl Cancer Inst 2003;95:556–58. [DOI] [PubMed] [Google Scholar]
  • 39.Heng D, Gao F, Jong R, et al. Risk factors for breast cancer associated with mammographic features in Singaporean chinese women. Cancer Epidemiol Biomarkers Prev 2004;13(11 Pt 1):1751–58. [PubMed] [Google Scholar]
  • 40.del Carmen MG, Hughes KS, Halpern E, et al. Racial differences in mammographic breast density. Cancer 2003;98:590–96. [DOI] [PubMed] [Google Scholar]
  • 41.El-Bastawissi AY, White E, Mandelson MT, Taplin S. Variation in mammographic breast density by race. Ann Epidemiol 2001;11:257–63. [DOI] [PubMed] [Google Scholar]
  • 42.Razzaghi H, Troester MA, Gierach GL, Olshan AF, Yankaskas BC, Millikan RC. Mammographic density and breast cancer risk in White and African American Women. Breast Cancer Res Treat 2012;135:571–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Zhang S, Ivy JS, Diehl KM, Yankaskas BC. The association of breast density with breast cancer mortality in African American and white women screened in community practice. Breast Cancer Res Treat 2013;137(1):273–83. [DOI] [PubMed] [Google Scholar]
  • 44.Li L, Ji J, Wang JB, Niyazi M, Qiao YL, Boffetta P. Attributable causes of breast cancer and ovarian cancer in China: reproductive factors, oral contraceptives and hormone replacement therapy. Chin J Cancer Res 2012;24:9–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Assi V, Warwick J, Cuzick J, Duffy SW. Clinical and epidemiological issues in mammographic density. Nat Rev Clin Oncol 2012;9:33–40. [DOI] [PubMed] [Google Scholar]
  • 46.Garrido-Estepa M, Ruiz-Perales F, Miranda J, et al. Evaluation of mammographic density patterns: reproducibility and concordance among scales. BMC Cancer 2010;10:485. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Data

Articles from International Journal of Epidemiology are provided here courtesy of Oxford University Press

RESOURCES